Cargando…
Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports
INTRODUCTION AND IMPORTANCE: Coronavirus Disease 2019 (COVID-19) has become a pandemic since the beginning of 2020. COVID-19 is also spreading very rapidly in Indonesia and so far, no definitive therapy has been found. CASE PRESENTATION: We report two cases of confirmed COVID-19 with moderate pneumo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165043/ https://www.ncbi.nlm.nih.gov/pubmed/34094533 http://dx.doi.org/10.1016/j.amsu.2021.102444 |
_version_ | 1783701229773258752 |
---|---|
author | Thabrani, Achmad Hadi, Wahid Syamsul Thobari, Jarir At Novianti, Zakiah Kurniyanto Juliana, Indah Suharto, Agus Danaswari, Atik Nuriyah Septiani, Ika Rhatomy, Sholahuddin |
author_facet | Thabrani, Achmad Hadi, Wahid Syamsul Thobari, Jarir At Novianti, Zakiah Kurniyanto Juliana, Indah Suharto, Agus Danaswari, Atik Nuriyah Septiani, Ika Rhatomy, Sholahuddin |
author_sort | Thabrani, Achmad |
collection | PubMed |
description | INTRODUCTION AND IMPORTANCE: Coronavirus Disease 2019 (COVID-19) has become a pandemic since the beginning of 2020. COVID-19 is also spreading very rapidly in Indonesia and so far, no definitive therapy has been found. CASE PRESENTATION: We report two cases of confirmed COVID-19 with moderate pneumonia, who received 400 ml of convalescent plasma and showed improvements in clinical, laboratory and radiological examinations. CLINICAL DISCUSSION: Passive immunotherapy is generally more effective when given early. Plasma transfusion is more beneficial when given before clinical conditions become severe. Some studies have shown that therapy with convalescent plasma can contribute to a longer survival and a lower length of stay. CONCLUSION: Convalescent plasma can be used as an adjunctive therapy option for patients with moderate COVID-19. |
format | Online Article Text |
id | pubmed-8165043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81650432021-06-01 Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports Thabrani, Achmad Hadi, Wahid Syamsul Thobari, Jarir At Novianti, Zakiah Kurniyanto Juliana, Indah Suharto, Agus Danaswari, Atik Nuriyah Septiani, Ika Rhatomy, Sholahuddin Ann Med Surg (Lond) Case Report INTRODUCTION AND IMPORTANCE: Coronavirus Disease 2019 (COVID-19) has become a pandemic since the beginning of 2020. COVID-19 is also spreading very rapidly in Indonesia and so far, no definitive therapy has been found. CASE PRESENTATION: We report two cases of confirmed COVID-19 with moderate pneumonia, who received 400 ml of convalescent plasma and showed improvements in clinical, laboratory and radiological examinations. CLINICAL DISCUSSION: Passive immunotherapy is generally more effective when given early. Plasma transfusion is more beneficial when given before clinical conditions become severe. Some studies have shown that therapy with convalescent plasma can contribute to a longer survival and a lower length of stay. CONCLUSION: Convalescent plasma can be used as an adjunctive therapy option for patients with moderate COVID-19. Elsevier 2021-05-31 /pmc/articles/PMC8165043/ /pubmed/34094533 http://dx.doi.org/10.1016/j.amsu.2021.102444 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Thabrani, Achmad Hadi, Wahid Syamsul Thobari, Jarir At Novianti, Zakiah Kurniyanto Juliana, Indah Suharto, Agus Danaswari, Atik Nuriyah Septiani, Ika Rhatomy, Sholahuddin Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports |
title | Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports |
title_full | Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports |
title_fullStr | Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports |
title_full_unstemmed | Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports |
title_short | Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports |
title_sort | convalescent plasma as a treatment modality for coronavirus disease 2019 in indonesia: a case reports |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165043/ https://www.ncbi.nlm.nih.gov/pubmed/34094533 http://dx.doi.org/10.1016/j.amsu.2021.102444 |
work_keys_str_mv | AT thabraniachmad convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT hadiwahidsyamsul convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT thobarijarirat convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT noviantizakiah convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT kurniyanto convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT julianaindah convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT suhartoagus convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT danaswariatiknuriyah convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT septianiika convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports AT rhatomysholahuddin convalescentplasmaasatreatmentmodalityforcoronavirusdisease2019inindonesiaacasereports |